{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:53:04Z","timestamp":1648648384802},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-1947-8-76","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T18:05:53Z","timestamp":1393437953000},"source":"Crossref","is-referenced-by-count":2,"title":["Bilateral renal ischemia after kyphoplasty and clodronate treatment: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Angela","family":"Notarnicola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Maccagnano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Casalino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Piazzolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"2716_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/00044011-200929060-00001","volume":"29","author":"B Frediani","year":"2009","unstructured":"Frediani B, Cavalieri L, Cremonesi G: Clodronic acid formulations available in Europe and their use in osteoporosis: a review. Clin Drug Investig. 2009, 29: 359-379. 10.2165\/00044011-200929060-00001.","journal-title":"Clin Drug Investig"},{"key":"2716_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1517\/14656566.3.11.1643","volume":"3","author":"V Ghinoi","year":"2002","unstructured":"Ghinoi V, Brandi ML: Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders. Expert Opin Pharmacother. 2002, 3: 1643-1656. 10.1517\/14656566.3.11.1643.","journal-title":"Expert Opin Pharmacother"},{"key":"2716_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","volume":"62","author":"PP Lehenkari","year":"2002","unstructured":"Lehenkari PP, Kellinsalmi M, N\u00e4p\u00e4nkangas JP, Ylitalo KV, M\u00f6nkk\u00f6nen J, Rogers MJ, Azhayev A, V\u00e4\u00e4n\u00e4nen HK, Hassinen IE: Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol Pharmacol. 2002, 62: 1255-1262.","journal-title":"Mol Pharmacol"},{"key":"2716_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1165\/ajrcmb.26.5.4748","volume":"26","author":"MA Koay","year":"2002","unstructured":"Koay MA, Gao X, Washington MK, Parman KS, Sadikot RT, Blackwell TS, Christman JW: Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am J Respir Cell Mol Biol. 2002, 26: 572-578. 10.1165\/ajrcmb.26.5.4748.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2716_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/B:IFLA.0000014707.49803.b6","volume":"28","author":"F Itoh","year":"2004","unstructured":"Itoh F, Aoyagi S, Kusama H, Kojima M, Kogo H: Effects of clodronate and alendronate on local and systemic changes in bone metabolism in rats with adjuvant arthritis. Inflammation. 2004, 28: 15-21.","journal-title":"Inflammation"},{"key":"2716_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0928-0987(98)00065-7","volume":"8","author":"N Makkonen","year":"1999","unstructured":"Makkonen N, Salminen A, Rogers MJ, Frith JC, Urtti A, Azhayeva E, M\u00f6nkk\u00f6nen J: Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci. 1999, 8: 109-118. 10.1016\/S0928-0987(98)00065-7.","journal-title":"Eur J Pharm Sci"},{"key":"2716_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s002239900353","volume":"61","author":"D Thi\u00e9baud","year":"1997","unstructured":"Thi\u00e9baud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P: An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int. 1997, 61: 386-392. 10.1007\/s002239900353.","journal-title":"Calcif Tissue Int"},{"key":"2716_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.62.4.378","volume":"62","author":"P Fietta","year":"2003","unstructured":"Fietta P, Manganelli P, Lodigiani L: Clodronate induced uveitis. Ann Rheum Dis. 2003, 62: 378-10.1136\/ard.62.4.378.","journal-title":"Ann Rheum Dis"},{"key":"2716_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ocl.2013.01.005","volume":"44","author":"AH Warriner","year":"2013","unstructured":"Warriner AH, Saag KG: Osteoporosis diagnosis and medical treatment. Orthop Clin North Am. 2013, 44: 125-135. 10.1016\/j.ocl.2013.01.005.","journal-title":"Orthop Clin North Am"},{"key":"2716_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/00044011-200929060-00001","volume":"29","author":"B Frediani","year":"2009","unstructured":"Frediani B, Cavalieri L, Cremonesi G: Clodronic acid formulations available in Europe and their use in osteoporosis: a review. Clin Drug Investig. 2009, 29: 359-379. 10.2165\/00044011-200929060-00001.","journal-title":"Clin Drug Investig"},{"key":"2716_CR11","first-page":"77","volume":"27","author":"G Rovetta","year":"2001","unstructured":"Rovetta G, Maggiani G, Molfetta L, Monteforte P: One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs Exp Clin Res. 2001, 27: 77-81.","journal-title":"Drugs Exp Clin Res"},{"key":"2716_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18773\/austprescr.2010.006","volume":"33","author":"KR Thomson","year":"2010","unstructured":"Thomson KR, Varma K: Safe use of radiographic contrast media. Aust Prescr. 2010, 33: 19-22.","journal-title":"Aust Prescr"},{"key":"2716_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s00586-005-0037-0","volume":"15","author":"SE Chung","year":"2006","unstructured":"Chung SE, Lee SH, Kim TH, Yoo KH, Jo BJ: Renal cement embolism during percutaneous vertebroplasty. Eur Spine J. 2006, 15: 590-594. 10.1007\/s00586-005-0037-0.","journal-title":"Eur Spine J"},{"key":"2716_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1055\/s-2004-813191","volume":"176","author":"MB Pitton","year":"2004","unstructured":"Pitton MB, Drees P, Schneider J, Brecher B, Herber S, Mohr W, Eckardt A, Heine J, Thelen M: [Evaluation of percutaneous vertebroplasty in osteoporotic vertebral fractures using a combination of CT fluoroscopy and conventional lateral fluoroscopy]. Rofo. 2004, 176: 1005-1012. 10.1055\/s-2004-813191.","journal-title":"Rofo"},{"key":"2716_CR15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/039463201002300215","volume":"23","author":"F Cacciapaglia","year":"2010","unstructured":"Cacciapaglia F, Spadaccio C, Gregorj C, Margiotta D, Coccia R, De Marco F, Chello M, Picardi A, Amoroso A, Afeltra A: Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells. Int J Immunopathol Pharmacol. 2010, 23: 535-542.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"Suppl 2","key":"2716_CR16","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1111\/j.1440-1797.2008.00994.x","volume":"13","author":"G Luxton","year":"2008","unstructured":"Luxton G, Langham R, Caring for Australians with Renal Impairment (CARI): The CARI guidelines: ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis. Nephrology. 2008, 13 (Suppl 2): S17-S23.","journal-title":"Nephrology"},{"key":"2716_CR17","doi-asserted-by":"publisher","first-page":"R1072","DOI":"10.1186\/ar1789","volume":"7","author":"B Bonaci-Nikolic","year":"2005","unstructured":"Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M: Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005, 7: R1072-R1081. 10.1186\/ar1789.","journal-title":"Arthritis Res Ther"},{"key":"2716_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/03009740701607117","volume":"37","author":"NH Denissen","year":"2008","unstructured":"Denissen NH, Peters JG, Masereeuw R, Barrera P: Can sulfasalazine therapy induce or exacerbate Wegener\u2019s granulomatosis?. Scand J Rheumatol. 2008, 37: 72-74. 10.1080\/03009740701607117.","journal-title":"Scand J Rheumatol"},{"key":"2716_CR19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/JCI119662","volume":"100","author":"DR Ralston","year":"1997","unstructured":"Ralston DR, Marsh CB, Lowe MP, Wewers MD: Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest. 1997, 100: 1416-1424. 10.1172\/JCI119662.","journal-title":"J Clin Invest"},{"key":"2716_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/ar1805","volume":"7","author":"A Wiik","year":"2005","unstructured":"Wiik A: Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther. 2005, 7: 191-192. 10.1186\/ar1805.","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-8-76\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-76","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T07:42:40Z","timestamp":1548142960000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-8-76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-8-76","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]},"article-number":"76"}}